Group One Trading
ANIK icon

Group One Trading’s Anika Therapeutics ANIK Stock Holding History

Group One Trading’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93K Hold
200
– – ﹤0.01% 6920
2026
Q1 		$2.9K Sell
200
-400
-67% -$4.64K ﹤0.01% 6934
2025
Q4 		$5.77K Sell
600
-300
-33% -$2.87K ﹤0.01% 7116
2025
Q3 		$8.46K Buy
900
+500
+125% +$4.78K ﹤0.01% 7275
2025
Q2 		$4.23K Buy
400
+300
+300% +$3.79K ﹤0.01% 7146
2025
Q1 		$1.5K Buy
+100
New +$1.66K ﹤0.01% 7085
2024
Q4 		– Sell
-100
Closed -$2.47K – 7214
2024
Q3 		$2.47K Buy
+100
New +$2.59K ﹤0.01% 6094
2021
Q2 		– Sell
-200
Closed -$8K – 8102
2021
Q1 		$8K Buy
+200
New +$7.59K ﹤0.01% 7103
2020
Q2 		– Sell
-5,700
Closed -$165K – 5752
2020
Q1 		$165K Sell
5,700
-5,400
-49% -$218K ﹤0.01% 2903
2019
Q4 		$576K Sell
11,100
-16,200
-59% -$941K ﹤0.01% 2321
2019
Q3 		$1.5M Buy
+27,300
New +$1.4M 0.01% 1420
2019
Q2 		– Sell
-30,500
Closed -$922K – 4906
2019
Q1 		$922K Buy
30,500
+26,500
+663% +$908K 0.01% 1464
2018
Q4 		$134K Buy
+4,000
New +$144K ﹤0.01% 2979
2017
Q4 		– Sell
-2,000
Closed -$116K – 4805
2017
Q3 		$116K Buy
2,000
+800
+67% +$41.8K ﹤0.01% 3137
2017
Q2 		$59K Buy
+1,200
New +$55.3K ﹤0.01% 3417
2013
Q3 		– Sell
-4,200
Closed -$71K – 5163
2013
Q2 		$71K Buy
+4,200
New +$60.6K ﹤0.01% 3119

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Group One Trading's ANIK Position: Q2 2026 in Review

Group One Trading opened a new position in Anika Therapeutics (ANIK) in Q2 2026: 200 shares worth $2.93K. The stake represents ﹤0.01% of the portfolio and ranks #6919 among its holdings. This is a return to the name: Group One Trading previously reported a position in ANIK as recently as Q4 2019.

Group One Trading first reported a position in ANIK in Q4 2013 and has held it in 18 quarters since. The position peaked at $503K in Q2 2015. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Group One Trading held 200 shares of Anika Therapeutics worth $2.93K as of Q2 2026.
  • Anika Therapeutics was a new Group One Trading position in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6919 holding.
  • Group One Trading first reported a position in Anika Therapeutics in Q4 2013 and has held it in 18 quarters since.
  • Group One Trading's Anika Therapeutics position peaked at $503K in Q2 2015.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.